Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

On the Brink? U.S. Carriers, Iran’s Threats and What It Means for Israel in Bible Prophecy

On the Brink? U.S. Carriers, Iran’s Threats and What It Means…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

From Regulation to Restriction: Europe’s Expanding Speech Laws and the Shadow of Prophecy

Europe’s Expanding Digital Crackdown Raises Free Speech Concerns Across…
Read more